Abstract
The pathophysiology, diagnosis, and medication-use implications of glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common enzyme deficiency in humans, are reviewed. We performed detailed search through electronic databases; PubMed, and EMBASE, for studies published in English language and human subjects thought instant to 2018. Glucose-6-phosphate dehydrogenase deficiency is a hereditary disorder that happens virtually solely in males. This problem mainly impacts red cell, which lug oxygen from the lungs to tissues throughout the body. In affected people, a problem in an enzyme called glucose-6-phosphate dehydrogenase causes red blood cells to break down prematurely. This destruction of red cell is called hemolysis. If transformations in the G6PD genetics decrease the quantity of glucose-6-phosphate dehydrogenase or change its structure, this enzyme can no more play its safety function. As a result, reactive oxygen species can build up and harm red blood cells.